← Insider buys
RARX

Ra Pharmaceuticals, Inc.

Novartis Bioventures Ltd sold $135K of Ra Pharmaceuticals, Inc.

10% owner

Sold$134,592
$25.14Price
5,353Shares

What RARX did after the filing

Prices for RARX after this filing aren't in yet.

Traded Thu, May 25. Filed Tue, May 30, 12:29 PM ET, during the session. Not investment advice.